Tissue Oxygenation During Heart Surgery

Sponsor
University Medical Center Groningen (Other)
Overall Status
Completed
CT.gov ID
NCT01347827
Collaborator
(none)
60
1
6
10

Study Details

Study Description

Brief Summary

The goal of this study is to determine if off-pump CABG surgery is associated with better cerebral tissue oxygenation when compared with on-pump CABG. In addition, the investigators would like to compare the results of two different monitors of brain tissue oxygenation with each other, and assess the correlation between brain tissue oxygenation and oxygenation measurements in renal and muscular tissue, as well as with conventional hemodynamic and metabolic variables, such as central venous oxygen saturation (ScvO2). Finally, the investigators aim to determine if duration and extent of cerebral oxygen desaturation predict outcome variables such as postoperative cognitive performance.

Condition or Disease Intervention/Treatment Phase
  • Device: measurements of brain tissue oxygenation
  • Device: measurements of brain tissue oxygenation

Study Design

Study Type:
Observational
Actual Enrollment :
60 participants
Time Perspective:
Prospective
Official Title:
Comparison of Cerebral Tissue Oxygen Desaturation in Patients Undergoing On-pump or Off-pump Coronary Artery Bypass Grafting
Study Start Date :
Jun 1, 2011
Actual Primary Completion Date :
Dec 1, 2011
Actual Study Completion Date :
Dec 1, 2011

Arms and Interventions

Arm Intervention/Treatment
on pump

Coronary artery bypass grafting (CABG)with with cardiopulmonary bypass

Device: measurements of brain tissue oxygenation
different monitors((the Hutchinson InSpectra™ StO2 Tissue Oxygenation Monitor) and in cerebral (ForeSight® Cerebral Oximeter and the Somanetics INVOS® Cerebral Oximeter ) and renal tissue (the Somanetics INVOS® Cerebral Oximeter)of brain tissue oxygenation with each other, and assess the correlation between brain tissue oxygenation and oxygenation measurements in renal and muscular tissue, as well as with conventional hemodynamic and metabolic variables, such as central venous oxygen saturation

off pump

off-pump CABG surgery

Device: measurements of brain tissue oxygenation
different monitors((the Hutchinson InSpectra™ StO2 Tissue Oxygenation Monitor) and in cerebral (ForeSight® Cerebral Oximeter and the Somanetics INVOS® Cerebral Oximeter ) and renal tissue (the Somanetics INVOS® Cerebral Oximeter) of brain tissue oxygenation with each other, and assess the correlation between brain tissue oxygenation and oxygenation measurements in renal and muscular tissue, as well as with conventional hemodynamic and metabolic variables, such as central venous oxygen saturation

Outcome Measures

Primary Outcome Measures

  1. incidence of significant brain tissue oxygen desaturation, defined as AUC40 > 600 %.sec (a function of both duration (in seconds) and severity (saturation < 40%) of desaturation). [3 months]

Secondary Outcome Measures

  1. Oxygenation measurements: Peripheral muscle StO2, cerebral and renal StO2, ScvO2, SaO2, arteriovenous oxygen difference, pO2 Acid-base status: pH, pCO2, HCO3-, ABE, lactate [3 months]

    To determine if oxygenation measurements obtained in peripheral (thenar) muscle, renal tissue and in cerebral tissue correlate with each other To determine if oxygenation measurements obtained in peripheral (thenar) muscle, renal tissue and in cerebral tissue correlate with conventional hemodynamic and metabolic variables such as central venous oxygen saturation (ScvO2).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥18 years

  • Informed patient consent

  • Coronary artery disease suitable for both on-pump and off-pump CABG surgery.

Exclusion Criteria:
  • History of head trauma or stroke causing significant active neurologic disease

  • History of neurosurgery

  • Severe or symptomatic carotid artery disease

  • Requirement for valve surgery in addition to CABG

  • Pre-existing acute or chronic renal dysfunction

  • Urgent or emergency surgery

  • Difficulty with cognitive testing: impaired hearing or eyesight, poor Dutch language comprehension, disability impairing the usage of the hand or arm.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Medical Center Groningen Groningen Netherlands

Sponsors and Collaborators

  • University Medical Center Groningen

Investigators

  • Principal Investigator: Thomas W.L. Scheeren, Prof.dr, University Medical Center Groningen

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
MMRF Struys, Prof.dr., University Medical Center Groningen
ClinicalTrials.gov Identifier:
NCT01347827
Other Study ID Numbers:
  • TO-CABG
First Posted:
May 4, 2011
Last Update Posted:
Jan 10, 2013
Last Verified:
Jan 1, 2013
Keywords provided by MMRF Struys, Prof.dr., University Medical Center Groningen

Study Results

No Results Posted as of Jan 10, 2013